On December 11, 2024, Indonesia released the draft amended Guidelines for Follow-up on Supervision Results of Traditional Medicines, Quasi Drugs, Health Supplements, and Cosmetics for public consultation. This Guidelines primarily outlines BPOM's supervision requirements for cosmetics, natural drugs, quasi drugs, and health supplements in circulation, including:

• Supervision items

• Supervision results

• Supervision methods

• Corresponding measures

The draft also includes five annexes clarifying follow-up supervision related to import, manufacturing, distribution, safety, efficacy, quality, labeling compliance, promotion, advertising, clinical trials, and pharmacovigilance for these product categories:

Appendix I: Guidelines for Follow-Up Supervision of Import, Manufacture, and Distribution

Appendix II: Guidelines for Follow-Up Supervision of Safety, Efficacy, Quality, and Labeling Compliance

Appendix III: Guidelines for Follow-Up Supervision of Promotion and Advertising

Appendix IV: Guidelines for Follow-Up Supervision of Clinical Trials

Appendix V: Guidelines for Follow-Up Supervision of Pharmacovigilance